Advances of the Correlation between Driver Gene Status and Immunotherapy 
in Non-small Cell Lung Cancer

Advances of the Correlation between Driver Gene Status and Immunotherapy 
in Non-small Cell Lung Cancer

In recent years, the checkpoint inhibitors targeted programmed cell death 1 (PD-1) and its ligand 1 (PD-1 ligand, PD-L1) achieved landmark significance in treating a variety of cancers including non-small cell lung cancer (NSCLC). However, current immunotherapy is not precise enough, only 15%-20% of...

Full description

Bibliographic Details
Main Authors: Jie CHEN, Da JIANG, Fang HUANG
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2019-04-01
Series:Chinese Journal of Lung Cancer
Subjects:
Lung neoplasms
Immnotherapy
Driver Gene
Hyperprogression
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2019.04.06

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2019.04.06

Similar Items